124 results on '"Ananya"'
Search Results
2. Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer
3. Impact of prostate radiotherapy on survival outcomes in clinically node-positive prostate cancer: A multicentre retrospective analysis
4. First-in-human technique translation of oxygen-enhanced MRI to an MR Linac system in patients with head and neck cancer
5. Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study
6. The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study
7. Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
8. Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity
9. Predicting outcomes in anal cancer patients using multi-centre data and distributed learning – A proof-of-concept study
10. From multisource data to clinical decision aids in radiation oncology: The need for a clinical data science community
11. REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer
12. Post-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapy
13. Outcomes of radiosensitisation in elderly patients with advanced bladder cancer
14. 2204: Motion management strategy and interobserver variation in abdominal OAR delineation using MRI
15. 2197: Evaluation of accumulated OAR dose DIR methods for MR-guided pancreas SABR
16. 1975: Validating MR Hypoxia Detection in Prostate Cancer using pimonidazole and GLUT1
17. 1920: Five fraction SBRT on the MR-Linac: time versus toxicity
18. 1461: Prostate cancer patients with lower muscle mass have increased late toxicities post-radiotherapy.
19. 1378: Genetically-based analysis of dose surface maps for assessing toxicity post-RT: an innovative method
20. 1300: Translation of Dynamic Contrast Enhanced MRI in Head and Neck Cancer to the MR Linac
21. 1242: Sensitivity of dose-response mapping model parameters at the bladder and rectum in prostate cancer
22. 1211: Prostate SABR radiotherapy on the MR Linac: how can we improve service efficiency?
23. 793: Baseline analysis of Q-ABC- prospective study comparing radiotherapy and surgery for bladder cancer
24. 29: Plasma proteomic profiling of bladder cancer patients with hypoxic tumours undergoing radiotherapy.
25. 2795: Analysis of workflow choice for MR-Linac prostate patients: adapt-to-shape vs adapt-to-position
26. 2506: Ethnicity in prostate cancer: the importance of asking
27. 2478: Developing geometrically robust diffusion-weighted MRI for head and neck imaging on an MR-Linac
28. 111 Radiation Therapy in Recurrent Endometrial Cancer Post Robotic Hysterectomy; an Institutional Review
29. The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients
30. Palliative radiotherapy in cancers of female genital tract: Outcomes and prognostic factors
31. A combined single high-dose rate brachytherapy boost with hypofractionated external beam radiotherapy results in a high rate of biochemical disease free survival in localised intermediate and high risk prostate cancer patients
32. Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I–II trials
33. Palliative radiotherapy in cancers of female genital tract: Outcomes and prognostic factors
34. 157: Radiation Oncology Resident Preferences for Virtual or In-Person Treatment Planning Review and Teaching Format
35. Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial
36. PO-1933 Can baseline or Ra-223-induced changes in the plasma predict progressive disease mCRPC patients?
37. PH-0656 Prediction of toxicity after prostate cancer RT: the value of a SNP-interaction polygenic risk score
38. PD-0766 Impact of treatment and clinical factors on worsening of functional scales after prostate cancer RT
39. OC-0513 Acute toxicity of hypo- and conventionally-fractionated radiosensitised bladder radiotherapy
40. PD-0925 An European cross-cultural analysis of worsening of functional scales in prostate cancer patients after RT
41. OC-0639 Towards personalised treatment for prostate cancer: biology improves image-based data mining models
42. 1344: Implementation of RTT-led OAR delineation training for pancreatic SABR on the MR Linac
43. Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
44. Post-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapy
45. 157: Radiation Oncology Resident Preferences for Virtual or In-Person Treatment Planning Review and Teaching Format
46. PO-1952 Quantification of MRI distortion in patients with metallic hip prosthesis: a feasibility study
47. PO-1798 Impact of inter-observer variability on MRI radiomic features in bladder cancer
48. PO-1778 MR radiomic features as predictive factors of ADT response in high-risk prostate cancer
49. PO-1949 Image registration guidelines impact on radiographer inter-observer variability for cervical cancer
50. PO-1346 Systematic Review of Salvage Reirradiation Options for Locally Recurrent Prostate Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.